Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 45 Neuroblastoma 16 Glioma 16 Brain Neoplasms 14 Astrocytoma 10 Neoplasms 8 Rhabdomyosarcoma 7 Sarcoma, Ewing 6 Recurrence 5 Oligodendroglioma 5 Medulloblastoma 5 Sarcoma 4 Osteosarcoma 4 Melanoma 4 Small Cell Lung Carcinoma 3 Neuroendocrine Tumors 3 Neuroectodermal Tumors, Primitive 3 Lymphoma 3 Gliosarcoma 3 Diffuse Intrinsic Pontine Glioma 3 Wilms Tumor 2 Rhabdoid Tumor 2 Pyloric Stenosis, Hypertrophic 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Ganglioneuroblastoma 2 Fallopian Tube Neoplasms 2 Ependymoma 2 Colorectal Neoplasms 2 Central Nervous System Neoplasms 2

Interventions

Diathermy 10 Radiotherapy 6 Surgical Procedures, Operative 2 Solutions 2 Hyperthermia, Induced 2 Hydrogen Peroxide 2 Drug Therapy 2 Brachytherapy 2 tislelizumab 1 anlotinib 1 Temozolomide 1 Saline Solution 1 Radiation 1 Patient Reported Outcome Measures 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Folfox protocol 1 Fluorouracil 1 Doxorubicin 1 Dacarbazine 1 Consolidation Chemotherapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hyperthermia × Temozolomide × Clear all

NCT06271421 2024-02-26

ANCHIALE

Poznan University of Medical Sciences

Phase NA Recruiting

Hyperthermia, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡